HEADER OXIDOREDUCTASE 29-MAR-08 3COT TITLE CRYSTAL STRUCTURE OF HUMAN LIVER DELTA(4)-3-KETOSTEROID 5BETA- TITLE 2 REDUCTASE (AKR1D1) IN COMPLEX WITH PROGESTERONE AND NADP. RESOLUTION: TITLE 3 2.03 A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXO-5-BETA-STEROID 4-DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE, ALDO-KETO REDUCTASE COMPND 5 FAMILY 1 MEMBER D1; COMPND 6 EC: 1.3.1.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1D1, SRD5B1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28(A) KEYWDS STEROID C-C DOUBLE BOND REDUCTION, 5BETA REDUCTASE, E120, BILE ACID KEYWDS 2 CATABOLISM, CYTOPLASM, DISEASE MUTATION, LIPID METABOLISM, NADP, KEYWDS 3 OXIDOREDUCTASE, STEROID METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR L.DI COSTANZO,J.DRURY,T.M.PENNING,D.W.CHRISTIANSON REVDAT 4 30-AUG-23 3COT 1 REMARK SEQADV REVDAT 3 24-FEB-09 3COT 1 VERSN REVDAT 2 24-JUN-08 3COT 1 JRNL REVDAT 1 08-APR-08 3COT 0 JRNL AUTH L.DI COSTANZO,J.E.DRURY,T.M.PENNING,D.W.CHRISTIANSON JRNL TITL CRYSTAL STRUCTURE OF HUMAN LIVER {DELTA}4-3-KETOSTEROID JRNL TITL 2 5{BETA}-REDUCTASE (AKR1D1) AND IMPLICATIONS FOR SUBSTRATE JRNL TITL 3 BINDING AND CATALYSIS. JRNL REF J.BIOL.CHEM. V. 283 16830 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18407998 JRNL DOI 10.1074/JBC.M801778200 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 71162.460 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.7 REMARK 3 NUMBER OF REFLECTIONS : 41289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1866 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5156 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 237 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5254 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 142 REMARK 3 SOLVENT ATOMS : 497 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.11000 REMARK 3 B22 (A**2) : -8.56000 REMARK 3 B33 (A**2) : 9.67000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.060 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.950 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 74.51 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NAP.PAR REMARK 3 PARAMETER FILE 4 : STR.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAP.TOP REMARK 3 TOPOLOGY FILE 4 : STR.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3COT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047035. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.008 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : ROSENBAUM-ROCK DOUBLE CRYSTAL REMARK 200 SAGITTAL FOCUSING MONOCHROMETER REMARK 200 AND VERTICAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44101 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3BUR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ISOPROPANOL 10%,PEG 4000, TRIS-HCL 100 REMARK 280 MM PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.87150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.29150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.71700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.29150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.87150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.71700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 8 36.57 -141.86 REMARK 500 ASN A 146 71.33 -154.86 REMARK 500 PHE A 200 77.79 -150.04 REMARK 500 THR A 224 171.23 75.84 REMARK 500 TRP A 230 -10.38 -144.53 REMARK 500 MET A 313 -7.80 -57.53 REMARK 500 HIS B 8 43.35 -144.29 REMARK 500 GLU B 28 106.92 -45.77 REMARK 500 THR B 224 171.99 77.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 3901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 3902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STR B 1500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STR A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CMF RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH CORTISOEN AND NADP DBREF 3COT A 1 326 UNP P51857 AK1D1_HUMAN 1 326 DBREF 3COT B 1 326 UNP P51857 AK1D1_HUMAN 1 326 SEQADV 3COT MET A -19 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY A -18 UNP P51857 EXPRESSION TAG SEQADV 3COT SER A -17 UNP P51857 EXPRESSION TAG SEQADV 3COT SER A -16 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -15 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -14 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -13 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -12 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -11 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A -10 UNP P51857 EXPRESSION TAG SEQADV 3COT SER A -9 UNP P51857 EXPRESSION TAG SEQADV 3COT SER A -8 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY A -7 UNP P51857 EXPRESSION TAG SEQADV 3COT LEU A -6 UNP P51857 EXPRESSION TAG SEQADV 3COT VAL A -5 UNP P51857 EXPRESSION TAG SEQADV 3COT PRO A -4 UNP P51857 EXPRESSION TAG SEQADV 3COT ARG A -3 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY A -2 UNP P51857 EXPRESSION TAG SEQADV 3COT SER A -1 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS A 0 UNP P51857 EXPRESSION TAG SEQADV 3COT MET B -19 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY B -18 UNP P51857 EXPRESSION TAG SEQADV 3COT SER B -17 UNP P51857 EXPRESSION TAG SEQADV 3COT SER B -16 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -15 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -14 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -13 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -12 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -11 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B -10 UNP P51857 EXPRESSION TAG SEQADV 3COT SER B -9 UNP P51857 EXPRESSION TAG SEQADV 3COT SER B -8 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY B -7 UNP P51857 EXPRESSION TAG SEQADV 3COT LEU B -6 UNP P51857 EXPRESSION TAG SEQADV 3COT VAL B -5 UNP P51857 EXPRESSION TAG SEQADV 3COT PRO B -4 UNP P51857 EXPRESSION TAG SEQADV 3COT ARG B -3 UNP P51857 EXPRESSION TAG SEQADV 3COT GLY B -2 UNP P51857 EXPRESSION TAG SEQADV 3COT SER B -1 UNP P51857 EXPRESSION TAG SEQADV 3COT HIS B 0 UNP P51857 EXPRESSION TAG SEQRES 1 A 346 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 346 LEU VAL PRO ARG GLY SER HIS MET ASP LEU SER ALA ALA SEQRES 3 A 346 SER HIS ARG ILE PRO LEU SER ASP GLY ASN SER ILE PRO SEQRES 4 A 346 ILE ILE GLY LEU GLY THR TYR SER GLU PRO LYS SER THR SEQRES 5 A 346 PRO LYS GLY ALA CYS ALA THR SER VAL LYS VAL ALA ILE SEQRES 6 A 346 ASP THR GLY TYR ARG HIS ILE ASP GLY ALA TYR ILE TYR SEQRES 7 A 346 GLN ASN GLU HIS GLU VAL GLY GLU ALA ILE ARG GLU LYS SEQRES 8 A 346 ILE ALA GLU GLY LYS VAL ARG ARG GLU ASP ILE PHE TYR SEQRES 9 A 346 CYS GLY LYS LEU TRP ALA THR ASN HIS VAL PRO GLU MET SEQRES 10 A 346 VAL ARG PRO THR LEU GLU ARG THR LEU ARG VAL LEU GLN SEQRES 11 A 346 LEU ASP TYR VAL ASP LEU TYR ILE ILE GLU VAL PRO MET SEQRES 12 A 346 ALA PHE LYS PRO GLY ASP GLU ILE TYR PRO ARG ASP GLU SEQRES 13 A 346 ASN GLY LYS TRP LEU TYR HIS LYS SER ASN LEU CYS ALA SEQRES 14 A 346 THR TRP GLU ALA MET GLU ALA CYS LYS ASP ALA GLY LEU SEQRES 15 A 346 VAL LYS SER LEU GLY VAL SER ASN PHE ASN ARG ARG GLN SEQRES 16 A 346 LEU GLU LEU ILE LEU ASN LYS PRO GLY LEU LYS HIS LYS SEQRES 17 A 346 PRO VAL SER ASN GLN VAL GLU CYS HIS PRO TYR PHE THR SEQRES 18 A 346 GLN PRO LYS LEU LEU LYS PHE CYS GLN GLN HIS ASP ILE SEQRES 19 A 346 VAL ILE THR ALA TYR SER PRO LEU GLY THR SER ARG ASN SEQRES 20 A 346 PRO ILE TRP VAL ASN VAL SER SER PRO PRO LEU LEU LYS SEQRES 21 A 346 ASP ALA LEU LEU ASN SER LEU GLY LYS ARG TYR ASN LYS SEQRES 22 A 346 THR ALA ALA GLN ILE VAL LEU ARG PHE ASN ILE GLN ARG SEQRES 23 A 346 GLY VAL VAL VAL ILE PRO LYS SER PHE ASN LEU GLU ARG SEQRES 24 A 346 ILE LYS GLU ASN PHE GLN ILE PHE ASP PHE SER LEU THR SEQRES 25 A 346 GLU GLU GLU MET LYS ASP ILE GLU ALA LEU ASN LYS ASN SEQRES 26 A 346 VAL ARG PHE VAL GLU LEU LEU MET TRP ARG ASP HIS PRO SEQRES 27 A 346 GLU TYR PRO PHE HIS ASP GLU TYR SEQRES 1 B 346 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 346 LEU VAL PRO ARG GLY SER HIS MET ASP LEU SER ALA ALA SEQRES 3 B 346 SER HIS ARG ILE PRO LEU SER ASP GLY ASN SER ILE PRO SEQRES 4 B 346 ILE ILE GLY LEU GLY THR TYR SER GLU PRO LYS SER THR SEQRES 5 B 346 PRO LYS GLY ALA CYS ALA THR SER VAL LYS VAL ALA ILE SEQRES 6 B 346 ASP THR GLY TYR ARG HIS ILE ASP GLY ALA TYR ILE TYR SEQRES 7 B 346 GLN ASN GLU HIS GLU VAL GLY GLU ALA ILE ARG GLU LYS SEQRES 8 B 346 ILE ALA GLU GLY LYS VAL ARG ARG GLU ASP ILE PHE TYR SEQRES 9 B 346 CYS GLY LYS LEU TRP ALA THR ASN HIS VAL PRO GLU MET SEQRES 10 B 346 VAL ARG PRO THR LEU GLU ARG THR LEU ARG VAL LEU GLN SEQRES 11 B 346 LEU ASP TYR VAL ASP LEU TYR ILE ILE GLU VAL PRO MET SEQRES 12 B 346 ALA PHE LYS PRO GLY ASP GLU ILE TYR PRO ARG ASP GLU SEQRES 13 B 346 ASN GLY LYS TRP LEU TYR HIS LYS SER ASN LEU CYS ALA SEQRES 14 B 346 THR TRP GLU ALA MET GLU ALA CYS LYS ASP ALA GLY LEU SEQRES 15 B 346 VAL LYS SER LEU GLY VAL SER ASN PHE ASN ARG ARG GLN SEQRES 16 B 346 LEU GLU LEU ILE LEU ASN LYS PRO GLY LEU LYS HIS LYS SEQRES 17 B 346 PRO VAL SER ASN GLN VAL GLU CYS HIS PRO TYR PHE THR SEQRES 18 B 346 GLN PRO LYS LEU LEU LYS PHE CYS GLN GLN HIS ASP ILE SEQRES 19 B 346 VAL ILE THR ALA TYR SER PRO LEU GLY THR SER ARG ASN SEQRES 20 B 346 PRO ILE TRP VAL ASN VAL SER SER PRO PRO LEU LEU LYS SEQRES 21 B 346 ASP ALA LEU LEU ASN SER LEU GLY LYS ARG TYR ASN LYS SEQRES 22 B 346 THR ALA ALA GLN ILE VAL LEU ARG PHE ASN ILE GLN ARG SEQRES 23 B 346 GLY VAL VAL VAL ILE PRO LYS SER PHE ASN LEU GLU ARG SEQRES 24 B 346 ILE LYS GLU ASN PHE GLN ILE PHE ASP PHE SER LEU THR SEQRES 25 B 346 GLU GLU GLU MET LYS ASP ILE GLU ALA LEU ASN LYS ASN SEQRES 26 B 346 VAL ARG PHE VAL GLU LEU LEU MET TRP ARG ASP HIS PRO SEQRES 27 B 346 GLU TYR PRO PHE HIS ASP GLU TYR HET NAP A3902 48 HET STR A1501 23 HET NAP B3901 48 HET STR B1500 23 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM STR PROGESTERONE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 STR 2(C21 H30 O2) FORMUL 7 HOH *497(H2 O) HELIX 1 1 GLY A 35 GLY A 48 1 14 HELIX 2 2 ALA A 55 GLN A 59 5 5 HELIX 3 3 ASN A 60 GLU A 74 1 15 HELIX 4 4 ARG A 78 ILE A 82 5 5 HELIX 5 5 TRP A 89 HIS A 93 5 5 HELIX 6 6 VAL A 94 GLU A 96 5 3 HELIX 7 7 MET A 97 GLN A 110 1 14 HELIX 8 8 ASN A 146 ALA A 160 1 15 HELIX 9 9 ASN A 172 ASN A 181 1 10 HELIX 10 10 GLN A 202 HIS A 212 1 11 HELIX 11 11 PRO A 237 LYS A 240 5 4 HELIX 12 12 ASP A 241 ASN A 252 1 12 HELIX 13 13 THR A 254 ARG A 266 1 13 HELIX 14 14 ASN A 276 GLN A 285 1 10 HELIX 15 15 THR A 292 ALA A 301 1 10 HELIX 16 16 LEU A 311 ARG A 315 5 5 HELIX 17 17 GLU B 28 THR B 32 5 5 HELIX 18 18 GLY B 35 GLY B 48 1 14 HELIX 19 19 ALA B 55 GLN B 59 5 5 HELIX 20 20 ASN B 60 GLU B 74 1 15 HELIX 21 21 ARG B 78 ILE B 82 5 5 HELIX 22 22 TRP B 89 HIS B 93 5 5 HELIX 23 23 VAL B 94 GLN B 110 1 17 HELIX 24 24 ASN B 146 ALA B 160 1 15 HELIX 25 25 ASN B 172 ASN B 181 1 10 HELIX 26 26 GLN B 202 HIS B 212 1 11 HELIX 27 27 PRO B 237 LYS B 240 5 4 HELIX 28 28 ASP B 241 LYS B 249 1 9 HELIX 29 29 THR B 254 ARG B 266 1 13 HELIX 30 30 ASN B 276 GLN B 285 1 10 HELIX 31 31 THR B 292 ALA B 301 1 10 HELIX 32 32 LEU B 311 ARG B 315 5 5 SHEET 1 A 2 ARG A 9 PRO A 11 0 SHEET 2 A 2 SER A 17 PRO A 19 -1 O ILE A 18 N ILE A 10 SHEET 1 B 8 LEU A 23 GLY A 24 0 SHEET 2 B 8 HIS A 51 ASP A 53 1 O ASP A 53 N LEU A 23 SHEET 3 B 8 PHE A 83 LEU A 88 1 O PHE A 83 N ILE A 52 SHEET 4 B 8 VAL A 114 ILE A 119 1 O ILE A 118 N LEU A 88 SHEET 5 B 8 VAL A 163 SER A 169 1 O SER A 165 N TYR A 117 SHEET 6 B 8 SER A 191 GLU A 195 1 O SER A 191 N VAL A 168 SHEET 7 B 8 VAL A 215 TYR A 219 1 O THR A 217 N VAL A 194 SHEET 8 B 8 VAL A 269 VAL A 270 1 O VAL A 269 N ALA A 218 SHEET 1 C 2 ALA A 124 PHE A 125 0 SHEET 2 C 2 TYR A 142 HIS A 143 -1 O HIS A 143 N ALA A 124 SHEET 1 D 2 ARG B 9 PRO B 11 0 SHEET 2 D 2 SER B 17 PRO B 19 -1 O ILE B 18 N ILE B 10 SHEET 1 E 8 LEU B 23 GLY B 24 0 SHEET 2 E 8 HIS B 51 ASP B 53 1 O ASP B 53 N LEU B 23 SHEET 3 E 8 PHE B 83 LEU B 88 1 O PHE B 83 N ILE B 52 SHEET 4 E 8 VAL B 114 ILE B 119 1 O LEU B 116 N GLY B 86 SHEET 5 E 8 VAL B 163 SER B 169 1 O SER B 165 N TYR B 117 SHEET 6 E 8 SER B 191 GLU B 195 1 O SER B 191 N VAL B 168 SHEET 7 E 8 VAL B 215 TYR B 219 1 O TYR B 219 N VAL B 194 SHEET 8 E 8 VAL B 269 VAL B 270 1 O VAL B 269 N ALA B 218 SITE 1 AC1 26 GLY B 24 THR B 25 TYR B 26 ASP B 53 SITE 2 AC1 26 TYR B 58 LYS B 87 SER B 169 ASN B 170 SITE 3 AC1 26 GLN B 193 TYR B 219 SER B 220 PRO B 221 SITE 4 AC1 26 LEU B 222 GLY B 223 THR B 224 SER B 225 SITE 5 AC1 26 LEU B 239 ALA B 256 ILE B 271 PRO B 272 SITE 6 AC1 26 LYS B 273 SER B 274 PHE B 275 ARG B 279 SITE 7 AC1 26 GLU B 282 ASN B 283 SITE 1 AC2 26 GLY A 24 THR A 25 TYR A 26 ASP A 53 SITE 2 AC2 26 TYR A 58 LYS A 87 SER A 169 ASN A 170 SITE 3 AC2 26 GLN A 193 TYR A 219 SER A 220 PRO A 221 SITE 4 AC2 26 LEU A 222 GLY A 223 THR A 224 SER A 225 SITE 5 AC2 26 LEU A 239 ALA A 256 ILE A 271 PRO A 272 SITE 6 AC2 26 LYS A 273 SER A 274 PHE A 275 ARG A 279 SITE 7 AC2 26 GLU A 282 ASN A 283 SITE 1 AC3 5 TYR B 26 TYR B 58 GLU B 120 TRP B 230 SITE 2 AC3 5 TRP B 314 SITE 1 AC4 5 TYR A 26 TYR A 58 GLU A 120 TYR A 132 SITE 2 AC4 5 TRP A 230 CRYST1 49.743 109.434 128.583 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020103 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009138 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007777 0.00000